Jeffers Nguyen

ORCID: 0000-0002-6750-6327
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiology practices and education
  • Diversity and Career in Medicine
  • COVID-19 and healthcare impacts
  • PARP inhibition in cancer therapy
  • Radiation Dose and Imaging
  • Innovations in Medical Education
  • Hip disorders and treatments
  • Hernia repair and management
  • Advanced Neuroimaging Techniques and Applications
  • Clinical Reasoning and Diagnostic Skills
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Mineralogy and Gemology Studies
  • Ovarian cancer diagnosis and treatment
  • Social Media in Health Education
  • Cancer-related Molecular Pathways
  • Advanced MRI Techniques and Applications
  • Quasicrystal Structures and Properties
  • Scientific Measurement and Uncertainty Evaluation
  • Mechanisms of cancer metastasis
  • Advanced Statistical Process Monitoring
  • Healthcare cost, quality, practices
  • Mobile Health and mHealth Applications
  • Artificial Intelligence in Healthcare and Education
  • X-ray Diffraction in Crystallography

Yale University
2021-2024

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2020-2022

National Cancer Institute
2016-2017

Johns Hopkins University
2017

Center for Cancer Research
2017

Bristol-Myers Squibb (Germany)
2017

AstraZeneca (Brazil)
2017

Cornell University
2013

Purpose Data suggest that DNA damage by poly (ADP-ribose) polymerase inhibition and/or reduced vascular endothelial growth factor signaling receptor may complement antitumor activity of immune checkpoint blockade. We hypothesize the programmed death-ligand 1 (PD-L1) inhibitor, durvalumab, olaparib, or cediranib combinations are tolerable and active in recurrent women's cancers. Patients Methods This phase I study tested durvalumab doublets parallel 3 + dose escalations. Durvalumab was...

10.1200/jco.2016.72.1340 article EN Journal of Clinical Oncology 2017-05-04

On March 11, 2020, the World Health Organization declared COVID-19 outbreak a global pandemic. Since then, government agencies have taken significant measures to contain spread of coronavirus, imposing aggressive such as travel bans and shelters-in-place. While these efforts flattened curve curtailed virus, they also produced negative collateral effects on economy medical education. Tens thousands third-year students across United States were abruptly frozen in their progress choosing...

10.1016/j.acra.2020.06.023 article EN other-oa Academic Radiology 2020-07-07

Timely reporting of CTA exams impacts management acute vascular pathology such as large vessel occlusions, arterial dissection, and ruptured aneurysm well a variety non-vascular pathologies. In this study, we examine potential modifiable factors impacting the timeliness performed in stroke code activations. Observational study head neck at single health system (3 emergency departments, 1550 inpatient beds) over four years (1/1/2019-12/31/2023). Patient age, patient sex, care setting, time...

10.3174/ajnr.a8660 article EN American Journal of Neuroradiology 2025-01-20

We review the way in which atomic tetrahedra composed of metallic elements pack naturally into fused icosahedra. Orthorhombic, hexagonal, and cubic intermetallic crystals based on this packing are all shown to be united having pseudo-fivefold rotational diffraction symmetry. A unified geometric model involving 600-cell is presented: accounts for observed symmetries among different Bravais lattice types. The vertex-, edge-, polygon-, cell-centered fused-icosahedral clusters. Vertex-centered...

10.1002/chem.201203758 article EN Chemistry - A European Journal 2013-06-18

10.1016/j.jacr.2020.08.008 article EN Journal of the American College of Radiology 2020-08-31

Abstract Background: Olaparib (OLA) is a PARP inhibitor approved for use in deleterious germline BRCA mutated recurrent or refractory ovarian cancer. Combining OLA with carboplatin (CARBO) could have additive effects based on platinum-DNA adducts requiring DNA repair. Preclinical data suggest greater cytotoxicity when CARBO given prior to OLA. However, the optimal treatment sequence of these agents has not been studied previously patients. We therefore investigated: 1) pharmacokinetics (PK)...

10.1158/1538-7445.am2016-2043 article EN Cancer Research 2016-07-15
Coming Soon ...